This topic contains a solution. Click here to go to the answer

Author Question: Warfarin skin necrosis occurs within the first 2 to 3 days after starting warfarin therapy because: ... (Read 71 times)

krzymel

  • Hero Member
  • *****
  • Posts: 548
Warfarin skin necrosis occurs within the first 2 to 3 days after starting warfarin therapy because:
 
  a. The platelet count decreases to fewer than 100  109/L, and significant bleeding occurs.
  b. Protein C decreases significantly before full anticoagulation, and skin thrombosis results.
  c. Prothrombin decreases rapidly generating less thrombin, and significant bleeding occurs.
  d. Plasminogen increases, and rapid clot lysis occurs.

Question 2

An INR of 6.5 is obtained on a patient taking warfarin. All quality control is acceptable. What should be done?
 
  a. Report the result.
  b. Report only the PT in seconds and ignore the INR.
  c. Send an e-mail to the healthcare provider.
  d. Call the healthcare provider immediately.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

blakeserpa

  • Sr. Member
  • ****
  • Posts: 338
Answer to Question 1

ANS: B
Protein C has a 6-hour half-life, and so it rapidly decreases when warfarin therapy is begun, along with factor VII (both are vitamin Kdependent proteins). Full anticoagulation with warfarin is not obtained until factors X and prothrombin are decreased to less than 50, requANS: B
Protein C has a 6-hour half-life, and so it rapidly decreases when warfarin therapy is begun, along with factor VII (both are vitamin Kdependent proteins). Full anticoagulation with warfarin is not obtained until factors X and prothrombin are decreased to less than 50, requiring 4 to 7 days based on their half-lives. Because protein C is important in controlling clot formation, its decrease actually puts the patient in a prethrombotic state until full anticoagulation is obtained.
iring 4 to 7 days based on their half-lives. Because protein C is important in controlling clot formation, its decrease actually puts the patient in a prethrombotic state until full anticoagulation is obtained.

Answer to Question 2

ANS: D
The clinical laboratory scientist must immediately call the healthcare provider because this is a critical INR result and he or she must be able to intervene with appropriate patient care. The call must be documented according to the protocol established by clinical scientists in the laboratory. This is essential to prevent a bad outcome for the patient.





 

Did you know?

The top five reasons that children stay home from school are as follows: colds, stomach flu (gastroenteritis), ear infection (otitis media), pink eye (conjunctivitis), and sore throat.

Did you know?

GI conditions that will keep you out of the U.S. armed services include ulcers, varices, fistulas, esophagitis, gastritis, congenital abnormalities, inflammatory bowel disease, enteritis, colitis, proctitis, duodenal diverticula, malabsorption syndromes, hepatitis, cirrhosis, cysts, abscesses, pancreatitis, polyps, certain hemorrhoids, splenomegaly, hernias, recent abdominal surgery, GI bypass or stomach stapling, and artificial GI openings.

Did you know?

Inotropic therapy does not have a role in the treatment of most heart failure patients. These drugs can make patients feel and function better but usually do not lengthen the predicted length of their lives.

Did you know?

On average, someone in the United States has a stroke about every 40 seconds. This is about 795,000 people per year.

Did you know?

Sildenafil (Viagra®) has two actions that may be of consequence in patients with heart disease. It can lower the blood pressure, and it can interact with nitrates. It should never be used in patients who are taking nitrates.

For a complete list of videos, visit our video library